Evidence map›Paper›PMID 42654041›Full record

ArticlePharmaceutics2026

Accuracy of Real-Time PK-Guided Melphalan Dosing in Achieving Target Exposure in Myeloma Patients Undergoing Autologous Transplant.

Kyeongmin Kim, Yizhen Guo, Min Hai, Kasey Hill, Nicole Abbott, Matias Eugenio Sanchez, Chukwuemeka Uzoka, Ana Maria Avila Rodriguez, John G Quigley, Nadim Mahmud and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Kyeongmin KimDepartment of Pharmacy Practice, University of Illinois Chicago, Chicago, IL 60607, USA.ORCID 0000-0002-8333-8001
Yizhen GuoDivision of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH 43210, USA.
Min HaiDivision of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0002-8675-8976
Kasey HillComprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Nicole AbbottComprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Matias Eugenio SanchezDivision of Hematology and Oncology, University of Illinois Chicago, Chicago, IL 60607, USA.
Chukwuemeka UzokaDivision of Hematology and Oncology, University of Illinois Chicago, Chicago, IL 60607, USA.
Ana Maria Avila RodriguezDivision of Hematology and Oncology, University of Illinois Chicago, Chicago, IL 60607, USA.
John G QuigleyDivision of Hematology and Oncology, University of Illinois Chicago, Chicago, IL 60607, USA.ORCID 0000-0003-3116-4545
Nadim MahmudDivision of Hematology and Oncology, University of Illinois Chicago, Chicago, IL 60607, USA.
Damiano RondelliDivision of Hematology and Oncology, University of Illinois Chicago, Chicago, IL 60607, USA.
Douglas W SborovHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.ORCID 0000-0003-4268-2698
Donald HarveyDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
Donald J IrbyDivision of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH 43210, USA.
Ajay K NookaDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
Madhav V DhodapkarDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
Jonathan L KaufmanDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
Nisha S JosephDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
Sagar LonialDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
Pritesh PatelDivision of Hematology and Oncology, University of Illinois Chicago, Chicago, IL 60607, USA.
Mitch A PhelpsDivision of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0002-1615-5280
Craig C HofmeisterDepartment of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.ORCID 0000-0003-4816-1607
Karen SweissDepartment of Pharmacy Practice, University of Illinois Chicago, Chicago, IL 60607, USA.

Funding

Gateway for Cancer Research 6703120565
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autologous transplantmelphalannonlinear mixed effects modelingpharmacokineticsPK-guided dosing

Identifiers

PMID42654041
PMCPMC13516206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.